1 |
Kara G, Calin GA, Ozpolat B. RNAi-based therapeutics and tumor targeted delivery in cancer. Advanced Drug Delivery Reviews 2022;182:114113. [DOI: 10.1016/j.addr.2022.114113] [Cited by in Crossref: 35] [Cited by in F6Publishing: 14] [Article Influence: 35.0] [Reference Citation Analysis]
|
2 |
Song HQ, Dou XB, Li RQ, Yu BR, Zhao NN, Xu FJ. A general strategy to prepare different types of polysaccharide-graft-poly(aspartic acid) as degradable gene carriers. Acta Biomater 2015;12:156-65. [PMID: 25448351 DOI: 10.1016/j.actbio.2014.10.041] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 4.0] [Reference Citation Analysis]
|
3 |
Goodarzi A, Taylor H. WITHDRAWN: Influence of polyaspartamide protonation on polyion complex formation with siRNA. Polymer 2013. [DOI: 10.1016/j.polymer.2013.11.020] [Reference Citation Analysis]
|
4 |
Bertin A. Polyelectrolyte Complexes of DNA and Polycations as Gene Delivery Vectors. Advances in Polymer Science 2013. [DOI: 10.1007/12_2013_218] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 2.2] [Reference Citation Analysis]
|
5 |
Cao J, Zhang L, Pan X, Cheng Z, Zhu X. RAFT Copolymerization of Glycidyl Methacrylate and N , N -Dimethylaminoethyl Methacrylate. Chin J Chem 2012;30:2138-44. [DOI: 10.1002/cjoc.201200625] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
|
6 |
Bruno K. Using drug-excipient interactions for siRNA delivery. Adv Drug Deliv Rev 2011;63:1210-26. [PMID: 21945846 DOI: 10.1016/j.addr.2011.09.003] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 3.2] [Reference Citation Analysis]
|
7 |
Ogris M, Wagner E. To Be Targeted: Is the Magic Bullet Concept a Viable Option for Synthetic Nucleic Acid Therapeutics? Human Gene Therapy 2011;22:799-807. [DOI: 10.1089/hum.2011.065] [Cited by in Crossref: 41] [Cited by in F6Publishing: 41] [Article Influence: 3.4] [Reference Citation Analysis]
|